A Study of VET3-TGI in Patients With Solid Tumors

This study is testing an experimental drug called VET3-TGI, given directly into tumors (intra-tumoral injection), in patients with advanced solid cancers. The drug is designed to stimulate the immune system to attack cancer cells. The trial focuses on safety and how the immune system responds. **You may be eligible if...** - You have an advanced, inoperable, or metastatic solid tumor (including breast, bladder, cervical, colorectal, ovarian, sarcoma, and others) - You have already tried or been unable to tolerate standard treatments - Your cancer is measurable on scans - You have at least one tumor accessible for injection - You are in good general health (ECOG 0 or 1) **You may NOT be eligible if...** - You have active brain metastases or cancer spread to the lining of the brain - You have a history of myocarditis (inflammation of the heart muscle) - You have HIV, active hepatitis B or C - You are on high-dose immune-suppressing medications - You need blood thinners that cannot be safely paused for biopsies Talk to your doctor to see if this trial is right for you.